Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Opalustre is a **topical dental microabrasion slurry** designed to remove superficial white, brown, or multicolored enamel defects, particularly those due to **enamel mottling from fluorosis**. It combines **chemical abrasion (6.6% hydrochloric acid)** with **gentle mechanical abrasion (silicon carbide microparticles)** for minimally invasive correction of surface enamel decalcification that is less than 0.2 mm in depth. The product is typically used in a single clinical visit, applied to the tooth surface with a slow-speed handpiece and bristle cup, and may be followed by fluoride treatment. Opalustre provides a conservative alternative to restorative approaches for the management of superficial enamel stains and decalcification, often in cases where traditional whitening has been ineffective. It is formulated for professional use only, and both clinician and patient require protective measures due to its caustic nature[3][4][5][6][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Opalustre.